Royal Bank of Canada’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.9M | Sell |
198,534
-30,197
| -13% | -$5.87M | 0.01% | 1046 |
|
|
2025
Q4 | $39.7M | Sell |
228,731
-243,498
| -52% | -$44.3M | 0.01% | 1067 |
|
|
2025
Q3 | $90M | Sell |
472,229
-415,899
| -47% | -$73.8M | 0.01% | 737 |
|
|
2025
Q2 | $160M | Buy |
888,128
+392,474
| +79% | +$68.2M | 0.03% | 462 |
|
|
2025
Q1 | $83.9M | Buy |
495,654
+172,518
| +53% | +$28.3M | 0.02% | 602 |
|
|
2024
Q4 | $48.7M | Buy |
323,136
+60,617
| +23% | +$9.43M | 0.01% | 852 |
|
|
2024
Q3 | $40.8M | Buy |
262,519
+18,781
| +8% | +$2.8M | 0.01% | 925 |
|
|
2024
Q2 | $33.4M | Buy |
243,738
+14,827
| +6% | +$2.03M | 0.01% | 968 |
|
|
2024
Q1 | $30.5M | Sell |
228,911
-757
| -0.3% | -$98.2K | 0.01% | 1017 |
|
|
2023
Q4 | $31.5M | Buy |
229,668
+99,993
| +77% | +$13.1M | 0.01% | 1009 |
|
|
2023
Q3 | $15.8M | Sell |
129,675
-51,236
| -28% | -$6.83M | ﹤0.01% | 1296 |
|
|
2023
Q2 | $25.4M | Buy |
180,911
+19,855
| +12% | +$2.74M | 0.01% | 1046 |
|
|
2023
Q1 | $22.8M | Sell |
161,056
-18,085
| -10% | -$2.59M | 0.01% | 1062 |
|
|
2022
Q4 | $28M | Buy |
179,141
+15,443
| +9% | +$2.22M | 0.01% | 960 |
|
|
2022
Q3 | $20.1M | Sell |
163,698
-37,611
| -19% | -$4.95M | 0.01% | 1063 |
|
|
2022
Q2 | $26.8M | Buy |
201,309
+33,762
| +20% | +$4.6M | 0.01% | 939 |
|
|
2022
Q1 | $22.9M | Sell |
167,547
-27,279
| -14% | -$3.8M | 0.01% | 1153 |
|
|
2021
Q4 | $33.7M | Sell |
194,826
-89,666
| -32% | -$13.6M | 0.01% | 1063 |
|
|
2021
Q3 | $41.3M | Buy |
284,492
+81,801
| +40% | +$12M | 0.01% | 857 |
|
|
2021
Q2 | $26.7M | Sell |
202,691
-42,539
| -17% | -$5.57M | 0.01% | 1129 |
|
|
2021
Q1 | $31.5M | Sell |
245,230
-24,643
| -9% | -$3.04M | 0.01% | 975 |
|
|
2020
Q4 | $32.2M | Buy |
269,873
+11,589
| +4% | +$1.41M | 0.01% | 938 |
|
|
2020
Q3 | $29.6M | Buy |
258,284
+30,794
| +14% | +$3.64M | 0.01% | 846 |
|
|
2020
Q2 | $25.9M | Sell |
227,490
-170,889
| -43% | -$18.1M | 0.01% | 892 |
|
|
2020
Q1 | $32M | Buy |
398,379
+53,453
| +15% | +$5.53M | 0.02% | 665 |
|
|
2019
Q4 | $36.8M | Buy |
344,926
+11,032
| +3% | +$1.15M | 0.01% | 771 |
|
|
2019
Q3 | $35.7M | Buy |
333,894
+16,955
| +5% | +$1.74M | 0.01% | 732 |
|
|
2019
Q2 | $32.3M | Buy |
316,939
+32,194
| +11% | +$3.09M | 0.01% | 795 |
|
|
2019
Q1 | $25.6M | Buy |
284,745
+187,077
| +192% | +$16.2M | 0.01% | 910 |
|
|
2018
Q4 | $8.13M | Sell |
97,668
-2,740
| -3% | -$257K | ﹤0.01% | 1643 |
|
|
2018
Q3 | $10.8M | Sell |
100,408
-387,704
| -79% | -$42.5M | ﹤0.01% | 1568 |
|
|
2018
Q2 | $53.7M | Buy |
488,112
+413,104
| +551% | +$43M | 0.02% | 529 |
|
|
2018
Q1 | $7.52M | Sell |
75,008
-107,867
| -59% | -$11M | ﹤0.01% | 1721 |
|
|
2017
Q4 | $18M | Buy |
182,875
+53,462
| +41% | +$5.07M | 0.01% | 1192 |
|
|
2017
Q3 | $12.1M | Buy |
129,413
+57,768
| +81% | +$6.13M | 0.01% | 1401 |
|
|
2017
Q2 | $7.97M | Buy |
71,645
+6,820
| +11% | +$721K | ﹤0.01% | 1652 |
|
|
2017
Q1 | $6.37M | Sell |
64,825
-174,469
| -73% | -$16.6M | ﹤0.01% | 1762 |
|
|
2016
Q4 | $22M | Buy |
239,294
+27,057
| +13% | +$2.33M | 0.01% | 1002 |
|
|
2016
Q3 | $18M | Sell |
212,237
-31,105
| -13% | -$2.61M | 0.01% | 1079 |
|
|
2016
Q2 | $19.8M | Sell |
243,342
-785
| -0.3% | -$59.8K | 0.01% | 970 |
|
|
2016
Q1 | $17.4M | Sell |
244,127
-17,285
| -7% | -$1.16M | 0.01% | 1011 |
|
|
2015
Q4 | $18.6M | Buy |
261,412
+132,133
| +102% | +$8.88M | 0.01% | 1022 |
|
|
2015
Q3 | $7.95M | Buy |
129,279
+5,141
| +4% | +$359K | 0.01% | 1295 |
|
|
2015
Q2 | $9M | Sell |
124,138
-36,377
| -23% | -$2.69M | 0.01% | 1269 |
|
|
2015
Q1 | $12.3M | Buy |
160,515
+13,847
| +9% | +$992K | 0.01% | 1091 |
|
|
2014
Q4 | $9.84M | Buy |
146,668
+8,318
| +6% | +$525K | 0.01% | 1235 |
|
|
2014
Q3 | $8.39M | Sell |
138,350
-417,177
| -75% | -$25.7M | 0.01% | 1306 |
|
|
2014
Q2 | $32.6M | Buy |
555,527
+421,173
| +313% | +$24.7M | 0.02% | 542 |
|
|
2014
Q1 | $7.78M | Sell |
134,354
-13,862
| -9% | -$743K | 0.01% | 1295 |
|
|
2013
Q4 | $7.93M | Sell |
148,216
-54,493
| -27% | -$3.23M | 0.01% | 1337 |
|
|
2013
Q3 | $12.5M | Buy |
202,709
+87,381
| +76% | +$5.23M | 0.01% | 1012 |
|
|
2013
Q2 | $6.99M | Buy |
+115,328
| New | +$6.87M | 0.01% | 1239 |
|
Other funds holding DGX
VCM
VPM
EIG
Royal Bank of Canada's DGX Position: Q1 2026 in Review
Royal Bank of Canada reduced its Quest Diagnostics (DGX) stake by 13% in Q1 2026, selling an estimated $5.87M and leaving 198,534 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1046.
Royal Bank of Canada first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $160M in Q2 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Royal Bank of Canada held 198,534 shares of Quest Diagnostics worth $38.9M as of Q1 2026.
- Royal Bank of Canada sold 30,197 Quest Diagnostics shares in Q1 2026, an estimated $5.87M.
- Quest Diagnostics made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1046 holding.
- Royal Bank of Canada first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Quest Diagnostics position peaked at $160M in Q2 2025.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.